Holen Sie sich die Stockscreener-App
3.46
10.36%
-0.40
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SLS?
Forum
Prognose
Aktiensplit
Sellas Life Sciences Group Inc Aktie (SLS) Neueste Nachrichten
SELLAS Stock Dips Amid Volatility After Warrant Exercise Update - StocksToTrade
SELLAS Life Sciences falls for fourth straight session — what’s driving the sell-off? - MSN
SELLAS Life Sciences Falls For Fourth Straight Session — What’s Driving The Sell Off? - Stocktwits
SLS Stock Plummets Amid Unfavorable Trial Results - timothysykes.com
Published on: 2026-01-08 22:04:52 - ulpravda.ru
Is SELLAS Life Sciences Group Inc. stock a top pick in earnings seasonJuly 2025 Catalysts & Expert-Curated Trade Recommendations - ulpravda.ru
Published on: 2026-01-09 05:48:17 - ulpravda.ru
Why SELLAS Life Sciences Group Inc. stock could outperform in 2025July 2025 Breakouts & AI Powered Buy/Sell Recommendations - ulpravda.ru
Investment Review: Why global investors buy SELLAS Life Sciences Group Inc. (RXK3) stock2025 Valuation Update & Scalable Portfolio Growth Ideas - ulpravda.ru
The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech - GlobeNewswire
SELLAS Life Sciences Group stock soars as it nears final analysis in cancer study - MSN
Dip Buying: How interest rate cuts could boost SELLAS Life Sciences Group Inc. stockJuly 2025 Earnings & AI Optimized Trading Strategy Guides - ulpravda.ru
Best Penny Stocks To Follow TodayJanuary 4th - MarketBeat
SLS Stock Breaches $5 Level After Over 3 Years: Retail Now Eyes Buyout For As Much As $25B - Asianet Newsable
Penny Stocks To Follow TodayJanuary 3rd - MarketBeat
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
A Look At SELLAS Life Sciences Group (SLS) Valuation As REGAL Phase 3 Trial Nears Final Event Trigger - simplywall.st
SELLAS Life Sciences Group (SLS) Is Up 50.8% After REGAL Trial Nears Final OS TriggerHas The Bull Case Changed? - Yahoo Finance
SELLAS Life Sciences (ASX:SLS) Shares Flat After Phase 3 Update - Kalkine Media
Is the Event-Driven REGAL Trial Timeline Reframing SELLAS Life Sciences Group’s (SLS) Risk-Reward Profile? - simplywall.st
Promising Penny Stocks To Add to Your WatchlistJanuary 1st - MarketBeat
SELLAS Life Sciences Stock Surges as Phase 3 Trial Nears Data Trigger - StocksToTrade
Why Is SLS Stock Drawing Significant Investor Attention Today? - Asianet Newsable
Ironwood Pharmaceuticals, Baidu, Vertiv Holdings And Other Big Stocks Moving Higher On Friday - Benzinga
SELLAS Life Sciences Group Stock (SLS) Opinions on Phase 3 Trial Progress - Quiver Quantitative
Weekly Buzz: ARS Pharma's Neffy Goes East, SLS Advances, A Signal Of Hope For IFRX? - RTTNews
SELLAS (SLS) stock jumps about 10% in premarket as REGAL AML trial milestone stays in focus - ts2.tech
Sellas Life Sciences Showcases Promising Phase 2 Data at Annual Meeting - StocksToTrade
Sellas Life Sciences Showcases Breakthroughs in AML Treatment - timothysykes.com
Axsome Therapeutics, Plug Power And Other Big Stocks Moving Higher On Wednesday - Benzinga
Largest borrow rate increases among liquid names - TipRanks
SELLAS Life Sciences Stock Surge: Buy or Wait? - StocksToTrade
SELLAS’s Therapy Triumph: Market Buzz - timothysykes.com
Discover the Top 5 Small-Cap Biotech Stocks in 2025 - Investing News Network
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):